Overall Status

Completed (2)

Recruiting (2)

Phase

n/a (2)

phase 1 (1)

phase 2 (1)

Sponsor

Arsenal Biosciences, Inc. (1)

Catalysis SL (1)

Karolinska Institutet (1)

University of Tennessee (1)

Collaborator

Region Skane (1)

University of Tennessee West Cancer Center (1)

Intervention

ab-1015 (1)

clinical alerts (1)

discharge instructions reminders (1)

ocoxin-viusid (1)

prompts to report symptoms via the web-enabled app (1)

sending of screening summon. (1)

Study Documents

Intervention Type

behavioral (1)

biological (1)

dietary supplement (1)

other (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

genital neoplasm, female

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Carcinoma, Ovarian Epithelial, Ovarian Tumors, Fallopian Tube Tumors Trial in Iowa City (AB-1015)

Recruiting

Carcinoma, Ovarian Epithelial
+8 more

AB-1015

Iowa City, Iowa

U. of Iowa Health Care

Jan 30, 2023

Carcinoma, Ovarian Tumor, Endocrine Gland Tumor Trial in Havana (Ocoxin-Viusid)

Completed

Carcinoma
+12 more

Ocoxin-Viusid

Havana, Cuba

National Institute of Oncology and Radiobiology (INOR)

Jul 5, 2022

Cervical Cancer, Uterine Cervical Tumor, Uterine Tumors Trial in Sweden (Sending of screening summon.)

Recruiting

Cervical Cancer
+9 more

Sending of screening summon.

Lund, Skåne, Sweden
+5 more

Apr 21, 2022

Genital Tumor, Female Trial in Southaven, Memphis (Discharge instructions reminders, Prompts to report symptoms via the

Completed

Genital Neoplasm, Female

Discharge instructions reminders
+2 more

Southaven, Mississippi
+2 more

Jun 22, 2018